Internal carotid artery stenting for intracranial atherosclerosis.

Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med (1991) 18.33

Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA (1995) 15.80

Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92

A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med (2001) 7.07

Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med (1985) 5.53

Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet (2013) 4.57

Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation (2005) 2.83

Surgical results of the Carotid Occlusion Surgery Study. J Neurosurg (2012) 1.73

Studies in cerebrovascular disease. III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system. Proc Staff Meet Mayo Clin (1955) 1.58

Elective stenting of symptomatic basilar artery stenosis. Stroke (2000) 1.52

Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. Cerebrovasc Dis (2014) 1.51

Population-based study of symptomatic internal carotid artery occlusion: incidence and long-term follow-up. Stroke (2004) 1.37

Is there a future for endovascular treatment of intracranial atherosclerotic disease after Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS)? Stroke (2012) 1.28

Elective stenting of symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol (2000) 1.26

Risk factors and stroke mechanisms in atherosclerotic stroke: intracranial compared with extracranial and anterior compared with posterior circulation disease. Stroke (2012) 1.23

Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol (2013) 1.23

Intracranial atherosclerosis. Lancet (2013) 1.02

Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a multicenter study. Stroke (2008) 1.00

The use of balloon-expandable stents in the management of intracranial arterial diseases: a 5-year single-center experience. AJNR Am J Neuroradiol (2005) 0.94

Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations. J Neuroimaging (2012) 0.93

Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis: a prospective cohort study after SAMMPRIS. J Neurointerv Surg (2014) 0.90

Long-term Outcomes of Drug-eluting Stents in Symptomatic Intracranial Stenosis. Neurointervention (2013) 0.90

Comparison between primary angioplasty and stent placement for symptomatic intracranial atherosclerotic disease: meta-analysis of case series. Neurosurgery (2009) 0.90

Drug eluting stents for symptomatic intracranial and vertebral artery stenosis. Interv Neuroradiol (2011) 0.88

Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting. J Neurointerv Surg (2009) 0.86

Intracranial arterial stenosis. J Stroke Cerebrovasc Dis (2013) 0.84

Pharos neurovascular intracranial stent: elective use for a symptomatic stenosis refractory to medical therapy. Catheter Cardiovasc Interv (2009) 0.84

The effectiveness of dual antiplatelet treatment in acute ischemic stroke patients with intracranial arterial stenosis: a subgroup analysis of CLAIR study. Int J Stroke (2012) 0.84

Early aggressive medical management for patients with symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis (2011) 0.83

The final SAMMPRIS results: a review. World Neurosurg (2014) 0.79

Initial experience with an everolimus-eluting, second-generation drug-eluting stent for treatment of intracranial atherosclerosis. J Neurointerv Surg (2010) 0.79

Effect of SAMMPRIS on endovascular interventions for intracranial atherosclerosis. Clin Neurol Neurosurg (2014) 0.78

Comparison of Drug-eluting Coronary Stents, Bare Coronary Stents and Self-expanding Stents in Angioplasty of Middle Cerebral Artery Stenoses. J Cerebrovasc Endovasc Neurosurg (2013) 0.78